Features | Partner Sites | Information | LinkXpress
Sign In
Schiller
Advantech Europe
GLOBETECH PUBLISHING

Hip Implants More Likely to Fail in Women

By HospiMedica International staff writers
Posted on 06 Mar 2013
A new study indicates that patient gender is important for patient management and device selection in total hip arthroplasty (THA) procedures.

Researchers at the Southern California Kaiser Permanente Research Group (San Diego, USA) reviewed the Kaiser Permanente system's registry of total joint replacements performed at 46 hospitals in California, Hawaii, Oregon, Washington, and Colorado by 319 different surgeons between 2001 and 2010. The data included arthroplasty procedure volumes; the patients and the implants they received (cemented, uncemented, or hybrid); and implant bearing surface, such as metal on metal, metal or ceramic on highly crosslinked polyethylene, or ceramic on ceramic. Only patients undergoing unilateral procedures were included in the analysis.

In all, about 58% of the 35,140 procedures were performed in women (mean age 65.7, versus 63.8 for men). The age difference between men and women was statistically significant, and women in the cohort tended to be slightly more likely to be white or Asian and to have osteoarthritis (OA), rheumatoid arthritis (RA), or dysplasia. They were less likely to be diabetic or obese and to have osteonecrosis or post-traumatic arthritis. The main outcome measures were failure of THA, defined as revision procedure for any reason, septic reason, or aseptic reason after the index procedure.

The results showed that failure rates for hip implants were 29% higher for women than men, after controlling for a variety of factors including device type; the risk appeared most prominent for aseptic revision compared with septic failure. Larger femoral head sizes appeared especially problematic for women. For head sizes of 36 mm or more, the failure rate in women was 49% higher. Not surprisingly, women were much less likely to have implant femoral head sizes of 36 mm or more (32.8% versus 55.4% for men).

The researchers also found that much of the increased risk for women seemed concentrated in metal-on-metal implants, with a doubling in risk for women versus men (19.4% versus 9.6%). Overall, however, ceramic or metal on highly cross-linked polyethylene were more popular for female patients. The DePuy resurfacing implant was used in 1.3% of women versus 2.6% of men. The study was published on February 18, 2013, in JAMA Internal Medicine.

“After considering patient-, surgery-, surgeon-, volume-, and implant-specific risk factors, women had a 29% higher risk of implant failure than men after THA,” concluded lead author Maria Inacio, MS, and colleagues. “With no significant increase in risk of septic failure for women, the results mean that factors other than infection are responsible for the higher overall revision rate.”

Related Links:

Kaiser Permanente Research Group



Anetic Aid
ECR
Cincinnati Sub-Zero

Channels

Women's Health

view channel

Maternal Iron Intake Linked to Autism Risk

A new study reveals that mothers of children with autism spectrum disorder (ASD) are less likely to have taken iron supplements before and during their pregnancies. Researchers at the University of California Davis (UCD; USA) and the UCD Mind Institute Clinic (Sacramento, CA, USA) analyzed data from 866 mother-child... Read more

Health IT

view channel

Doctors Claim EHRs Do Not Save Money or Time

A recent survey claims that 75% of physicians in the United States who use electronic health records (EHRs) say they are not cost- or time-effective, but do have value in terms of providing data. The Deloitte (New York, NY, USA) 2014 Survey examined US physicians’ current use and overall views of mobile health (mHealth)... Read more

Hospital News

view channel

Apollo Hospitals Opens New Diabetes Clinics

Apollo Hospitals (Kolkata, India) has partnered with pharmaceutical giant Sanofi (Paris, France) to improve access to treatment for diabetics. The joint venture, to be named Apollo Sugar Clinics, will be a subsidiary of Apollo Health and Lifestyle, with Sanofi proposing to buy a 20% stake. For the first phase of the... Read more

Business

view channel

Growth Expected for Global Patient Monitoring Market

The global advanced patient monitoring market has benefited from demand at health facilities and in the home treatment markets. These are the latest findings of Kalorama Information (New York, NY, USA), an independent medical market research firm. The global advanced patient monitoring market includes equipment and devices... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.